参考文献/References:
[1]裴倩倩,高云,王春梅.中性粒细胞与淋巴细胞比值辅助诊断老年社区获得性尿路感染的研究[J].中华全科医学,2024,8(7):81-83.[2]王文娟,张瑜,王凯.在尿常规临床检验中应用分析前质量控制措施的临床效果[J].实用检验医师杂志,2023,15(2):155-158.[3]陈文青,聂力平.不同检测方法联合检测对尿路感染的诊断价值[J].慢性病学杂志,2024,25(2):286-288.[4]陈王超,张新军.白蛋白与球蛋白比率在输尿管镜碎石术后并发发热性尿路感染早期诊断中的价值[J].现代临床医学,2024,24(7):51-54.[5]杨铭理,陈瑞英.尿液定量分析参数和尿常规白细胞酯酶检测在尿路感染中的临床意义[J].江西医药,2022,57(10):1562-1564,1571.[6]吴绍辉.细菌定量计数结合尿沉渣白细胞检测与尿细菌培养诊断尿路感染的比较研究[J].临床检验杂志(电子版),2017,6(4):655-656.[7]陶炜,刘万宗,董小康,等.US-BACT、US-WBC及BWBC在诊断细菌性尿路感染中的应用[J].分子诊断与治疗杂志,2021,13(4):543-546. [8]瞿易,唐友东.尿白细胞、细菌及亚硝酸盐联合检测在尿路感染诊断中的应用价值[J].包头医学院学报,2020,34(1):73-74.[9]吴亚丽.尿常规亚硝酸盐白细胞酯酶检测和细菌计数对尿路感染的诊断价值[J].山西医药杂志,2021,50(14):2212-2213.[10]陈运娇,罗标,陆居文,等.细菌培养与尿沉渣细菌定量分析在尿路感染诊断价值对比分析[J].黑龙江医药,2019,32(5):1223-1224.[11]周先明,疏仁义,李建.血清炎症指标对老年BPH患者术后尿路感染的预测价值[J].中国老年学杂志,2021,41(15):3227-3230.[12]时翠销,王刚,李亚娟,等.尿路感染B群链球菌的耐药特征与CAMP试验敏感性分析[J].安徽医科大学学报,2021,56(10):1516-1520.[13]杜颖,冯景,杨传信,等.尿常规及尿液定量分析参数在早期尿路感染经验性用药中的应用[J].检验医学,2020,35(10):1046-1048.[14]彭皎.细菌定量计数联合尿沉渣白细胞检验在尿路感染诊断中的应用价值分析[J].现代诊断与治疗,2020,31(8):1179-1181.[15]梅方超,戴海英,尚小玲,等.尿液HBP,LE,U-NIT和WBC联合检测与尿液细菌定量培养对急性尿道感染的诊断意义[J].现代检验医学杂志,2018,33(5):126-128.[16]陈曼娜,林少荣,张俊钿.尿十联检验联合细菌定量检测在尿路感染诊断中的应用价值分析[J].中国医学工程,2021,29(2):82-85.[17]纪凤卿,刘伟民,陈君颖,等.UN2000尿液全自动化流水线系统和中段尿培养检测在尿路感染诊断中的应用[J].检验医学与临床,2021,18(23):3468-3471.[18]付晓峰.尿β2-MG、WBC水平检测对尿路感染的诊断价值分析[J].辽宁医学杂志,2022,36(4):81-83.[19]赵莹.尿干化学法联合尿沉渣法用于尿液检验的临床效果观察[J].中国基层医药,2020,27(7):776-780.[20]魏颖.细菌定量计数结合尿白细胞检测在尿路感染中的应用[J].西藏医药,2020,41(1):27-28.[21]李果,张驰,黄铭,等.UF-1000i自动尿液分析仪对尿路感染的诊断价值[J].实验与检验医学,2021,39(1):70-71,117.[22]房宇.细菌定量计数联合尿沉渣白细胞检验在尿路感染诊断中的应用价值[J].系统医学,2022,7(10):72-75.
相似文献/References:
[1]柳 梅.头孢哌酮钠舒巴坦钠治疗糖尿病并发尿路感染的
临床效果观察[J].医学信息,2018,31(07):139.[doi:10.3969/j.issn.1006-1959.2018.07.047]
LIU Mei.Clinical Efficacy of Cefoperazone Sodium and Sulbactam Sodium in Treatment of Diabetes Complicated with Urinary Tract Infection[J].Journal of Medical Information,2018,31(04):139.[doi:10.3969/j.issn.1006-1959.2018.07.047]
[2]钱菲菲,周 易.尿路感染诊断治疗中临床微生物检验的病原菌结果分析[J].医学信息,2022,35(23):159.[doi:10.3969/j.issn.1006-1959.2022.23.035]
QIAN Fei-fei,ZHOU Yi.Analysis of Pathogenic Bacteria Results of Clinical Microbiological Examination in the Diagnosis and Treatment of Urinary Tract Infection[J].Journal of Medical Information,2022,35(04):159.[doi:10.3969/j.issn.1006-1959.2022.23.035]
[3]雷 欣,陈筱云.糖尿病合并尿路感染中医临证治验[J].医学信息,2021,34(07):162.[doi:10.3969/j.issn.1006-1959.2021.07.046]
[4]茹银转,胡桂贞,陈云开,等.2018年~2020年某基层医院尿路感染的细菌分布及耐药状况调查[J].医学信息,2021,34(12):148.[doi:10.3969/j.issn.1006-1959.2021.12.040]
RU Yin-zhuan,HU Gui-zhen,CHEN Yun-kai,et al.Survey of Bacterial Distribution and Drug Resistance of Urinary Tract Infections in a Primary Hospital from 2018 to 2020[J].Journal of Medical Information,2021,34(04):148.[doi:10.3969/j.issn.1006-1959.2021.12.040]
[5]魏长斌.头孢哌酮钠舒巴坦钠对糖尿病合并尿路感染的疗效及安全性分析[J].医学信息,2021,34(14):151.[doi:10.3969/j.issn.1006-1959.2021.14.042]
WEI Chang-bin.Analysis of the Efficacy and Safety of Cefoperazone Sodium and Sulbactam Sodium on Diabetes Complicated with Urinary Tract Infection[J].Journal of Medical Information,2021,34(04):151.[doi:10.3969/j.issn.1006-1959.2021.14.042]
[6]肖春芳.尿路感染患者奇异变形杆菌分布及耐药性分析[J].医学信息,2021,34(24):187.[doi:10.3969/j.issn.1006-1959.2021.24.051]
XIAO Chun-fang.Distribution and Drug Resistance of Proteus Mirabilis in Patients with Urinary Tract Infection[J].Journal of Medical Information,2021,34(04):187.[doi:10.3969/j.issn.1006-1959.2021.24.051]
[7]邹 莉,邹长娇,陈丽华.新型泌尿外科护理管理模式对外科住院患者治疗及降低院内尿路感染的影响[J].医学信息,2024,37(05):161.[doi:10.3969/j.issn.1006-1959.2024.05.030]
ZOU Li,ZOU Chang-jiao,CHEN Li-hua.Effect of New Urological Nursing Management Model on the Treatment and the Reduction of Nosocomial Urinary Tract Infection for Surgical Inpatients[J].Journal of Medical Information,2024,37(04):161.[doi:10.3969/j.issn.1006-1959.2024.05.030]
[8]李文花,王 岚.芙蓉尿感清治疗尿路感染作用机制的网络药理学分析[J].医学信息,2024,37(14):1.[doi:10.3969/j.issn.1006-1959.2024.14.001]
LI Wen-hua,WANG Lan.Network Pharmacological Analysis of the Mechanism of Furong Niaoganqing in the Treatment of Urinary Tract Infection[J].Journal of Medical Information,2024,37(04):1.[doi:10.3969/j.issn.1006-1959.2024.14.001]
[9]郭伟强,韦碧柳.降钙素原在老年患者中应用的文献计量学分析[J].医学信息,2024,37(14):38.[doi:10.3969/j.issn.1006-1959.2024.14.007]
GUO Wei-qiang,WEI Bi-liu.Bibliometric Analysis of the Application of Procalcitonin in Elderly Patients[J].Journal of Medical Information,2024,37(04):38.[doi:10.3969/j.issn.1006-1959.2024.14.007]